Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : NIFTY NINE IN NINETY NINE PLUS ONE -- Ignore unavailable to you. Want to Upgrade?

To: Arthur Radley who wrote (117)	1/12/1999 4:15:00 AM
From: Mike McFarland	Read Replies (1) \| Respond to of 613

Gene Logic is certainly doing well for you lately. I had looked the group over awhile back...and unfortunately had a trade ready to go with INCY at $22, but never got in. I see even affx is doing well since last fall, although not outperforming the market. Here is a post from the yahoo hysq thread messages.yahoo.com@m2.yahoo.com I too have noticed that although my portfolio keeps nudging up each day...most of the biotech stocks that I watch have not performed...in fact, even big cap pharma did lousy on Monday. The market is not especially strong right now I think...sure the internuts are going wild, but not a lot else. I cant complain too much...the mm microcap fund is holding it's own, heheh. techstocks.com BTRN is the laggard, but I am hoping that Medimmune will help Biotransplant out a bit when they do their presentation tommorrow at H&Q. Here is the appropriate recap query recap.com and the old news from Yahoo biz.yahoo.com As with all of my picks, I beleive that a modest amount of DD has unearthed ten bagger material trading at a low price. However, I am certainly not qualified to give the odds for success...and that is the key-- even the experts are not able to handicap these things. Investing. --Mike